Hayley is a Principal in CRA’s Life Sciences Practice. She has a background in public health and over 7 years as a strategy consultant primarily serving pharmaceutical and biotech clients.
She has a demonstrated track record of connecting evidence sources (i.e. primary market research and large-format data sets) to generate best-possible insights to support strategic decision making for in-line and pipeline assets with a specialty in assessment of new opportunities.
Hayley works across a wide variety of therapeutic areas but has specific experience in infectious diseases, immunology, and rare diseases. Prior to joining CRA, she worked for C1 Consulting and Rabin Martin.